Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from Crinetics Pharmaceuticals (CRNX) is now available.
Marc Wilson has announced his resignation as the Chief Financial Officer of the Company, effective once a successor is found and transitioned into the role. The company is actively searching for a new CFO. Wilson’s decision to leave is due to personal reasons and not due to any disputes or disagreements with the company’s operations or practices.
For detailed information about CRNX stock, go to TipRanks’ Stock Analysis page.